- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: 97.22%
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
| EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | -0.71 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2022 (9) | -0.16 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2021 (8) | -0.13 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2020 (7) | 0.72 | 0 | 0.70 | 0 | 0.00 | 0 | 97.22 | 0 | 0.00 | 0 | 97.22 | 0 |
| 2019 (6) | -0.74 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2018 (5) | -0.29 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2017 (4) | -0.36 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| 2016 (3) | 0.07 | 600.0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
| EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 24Q3 (20) | 0.28 | 0 | 211.11 | 0.33 | 512.5 | 512.5 | 0.40 | 233.33 | 157.14 |
| 24Q2 (19) | 0.00 | -100.0 | 100.0 | -0.08 | -33.33 | 80.95 | 0.12 | 0.0 | 115.19 |
| 24Q1 (18) | 0.12 | 1300.0 | 124.49 | -0.06 | 62.5 | 89.29 | 0.12 | 116.9 | 124.49 |
| 23Q4 (17) | -0.01 | -111.11 | 96.55 | -0.16 | -100.0 | 30.43 | -0.71 | -1.43 | -343.75 |
| 23Q3 (16) | 0.09 | 131.03 | 0 | -0.08 | 80.95 | 33.33 | -0.70 | 11.39 | -638.46 |
| 23Q2 (15) | -0.29 | 40.82 | -341.67 | -0.42 | 25.0 | -400.0 | -0.79 | -61.22 | -707.69 |
| 23Q1 (14) | -0.49 | -68.97 | 0 | -0.56 | -143.48 | -2700.0 | -0.49 | -206.25 | 0 |
| 22Q4 (13) | -0.29 | 0 | -270.59 | -0.23 | -91.67 | -330.0 | -0.16 | -223.08 | -23.08 |
| 22Q3 (12) | 0.00 | -100.0 | 100.0 | -0.12 | -185.71 | -140.0 | 0.13 | 0.0 | 143.33 |
| 22Q2 (11) | 0.12 | 0 | 180.0 | 0.14 | 800.0 | 380.0 | 0.13 | 0 | 152.0 |
| 22Q1 (10) | 0.00 | -100.0 | 100.0 | -0.02 | -120.0 | 50.0 | 0.00 | 100.0 | 100.0 |
| 21Q4 (9) | 0.17 | 440.0 | -46.88 | 0.10 | 300.0 | -85.92 | -0.13 | 56.67 | -118.06 |
| 21Q3 (8) | -0.05 | 66.67 | -102.6 | -0.05 | 0.0 | -102.45 | -0.30 | -20.0 | -175.0 |
| 21Q2 (7) | -0.15 | -50.0 | 82.14 | -0.05 | -25.0 | 91.94 | -0.25 | -150.0 | 83.55 |
| 21Q1 (6) | -0.10 | -131.25 | 85.29 | -0.04 | -105.63 | 94.12 | -0.10 | -113.89 | 85.29 |
| 20Q4 (5) | 0.32 | -83.33 | 150.0 | 0.71 | -65.2 | 222.41 | 0.72 | 80.0 | 197.3 |
| 20Q3 (4) | 1.92 | 328.57 | 0.0 | 2.04 | 429.03 | 0.0 | 0.40 | 126.32 | 0.0 |
| 20Q2 (3) | -0.84 | -23.53 | 0.0 | -0.62 | 8.82 | 0.0 | -1.52 | -123.53 | 0.0 |
| 20Q1 (2) | -0.68 | -6.25 | 0.0 | -0.68 | -17.24 | 0.0 | -0.68 | 8.11 | 0.0 |
| 19Q4 (1) | -0.64 | 0.0 | 0.0 | -0.58 | 0.0 | 0.0 | -0.74 | 0.0 | 0.0 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 4.45 | -17.17 | 32.44 | 41.54 | 7.46 | 14.21 | N/A | - | ||
| 2024/9 | 5.37 | 22.45 | 9.83 | 37.09 | 5.08 | 14.48 | 0.73 | - | ||
| 2024/8 | 4.39 | -6.9 | -12.87 | 31.72 | 4.32 | 12.93 | 0.81 | - | ||
| 2024/7 | 4.71 | 23.21 | 12.89 | 27.33 | 7.73 | 11.67 | 0.9 | - | ||
| 2024/6 | 3.83 | 22.23 | -5.93 | 22.62 | 6.72 | 10.23 | 0.93 | - | ||
| 2024/5 | 3.13 | -4.5 | -8.75 | 18.79 | 9.73 | 10.82 | 0.88 | - | ||
| 2024/4 | 3.28 | -25.71 | -3.39 | 15.66 | 14.35 | 10.99 | 0.86 | - | ||
| 2024/3 | 4.41 | 33.87 | 46.06 | 12.38 | 20.2 | 12.38 | 0.63 | - | ||
| 2024/2 | 3.3 | -29.46 | -9.06 | 7.97 | 9.47 | 11.74 | 0.66 | - | ||
| 2024/1 | 4.67 | 23.85 | 27.87 | 4.67 | 27.87 | 11.57 | 0.67 | - | ||
| 2023/12 | 3.77 | 20.83 | -12.3 | 45.55 | -25.7 | 10.26 | 0.9 | - | ||
| 2023/11 | 3.12 | -7.08 | -28.86 | 41.78 | -26.72 | 11.38 | 0.81 | - | ||
| 2023/10 | 3.36 | -31.31 | -20.32 | 38.66 | -26.54 | 13.29 | 0.7 | - | ||
| 2023/9 | 4.89 | -2.85 | -3.41 | 35.3 | -27.08 | 14.11 | 0.67 | - | ||
| 2023/8 | 5.04 | 20.62 | -7.98 | 30.4 | -29.85 | 13.28 | 0.71 | - | ||
| 2023/7 | 4.18 | 2.67 | -20.01 | 25.37 | -33.01 | 11.67 | 0.81 | - | ||
| 2023/6 | 4.07 | 18.56 | -35.45 | 21.19 | -35.08 | 10.89 | 1.03 | - | ||
| 2023/5 | 3.43 | 1.09 | -31.19 | 17.12 | -35.0 | 9.84 | 1.14 | - | ||
| 2023/4 | 3.39 | 12.3 | -25.65 | 13.69 | -35.89 | 10.04 | 1.12 | - | ||
| 2023/3 | 3.02 | -16.65 | -53.05 | 10.3 | -38.67 | 10.3 | 1.12 | 史瓦帝尼產區因更新設備，工廠申請停工一個月，故營收下降。 | ||
| 2023/2 | 3.62 | -0.81 | -26.45 | 7.28 | -29.73 | 11.58 | 1.0 | - | ||
| 2023/1 | 3.65 | -15.05 | -32.71 | 3.65 | -32.71 | 12.35 | 0.94 | - | ||
| 2022/12 | 4.3 | -1.98 | -32.95 | 61.32 | -7.66 | 12.91 | 0.97 | - | ||
| 2022/11 | 4.39 | 4.06 | -29.82 | 57.01 | -4.95 | 13.67 | 0.91 | - | ||
| 2022/10 | 4.22 | -16.73 | -31.05 | 52.62 | -2.06 | 14.76 | 0.85 | - | ||
| 2022/9 | 5.07 | -7.46 | -8.51 | 48.41 | 1.66 | 15.76 | 0.86 | - | ||
| 2022/8 | 5.47 | 4.86 | 4.67 | 43.34 | 3.0 | 17.0 | 0.8 | - | ||
| 2022/7 | 5.22 | -17.15 | -6.5 | 37.87 | 2.76 | 16.51 | 0.82 | - | ||
| 2022/6 | 6.3 | 26.39 | 15.01 | 32.65 | 4.41 | 15.85 | 0.89 | - | ||
| 2022/5 | 4.99 | 9.23 | 7.2 | 26.34 | 2.16 | 15.98 | 0.88 | - | ||
| 2022/4 | 4.56 | -29.08 | -6.43 | 21.36 | 1.05 | 15.93 | 0.89 | - | ||
| 2022/3 | 6.44 | 30.56 | 18.56 | 16.8 | 3.3 | 16.8 | 0.92 | - | ||
| 2022/2 | 4.93 | -9.25 | -20.27 | 10.36 | -4.34 | 16.78 | 0.92 | - | ||
| 2022/1 | 5.43 | -15.36 | 16.84 | 5.43 | 16.84 | 18.1 | 0.85 | - | ||
| 2021/12 | 6.42 | 2.58 | -9.74 | 66.41 | -22.76 | 18.79 | 0.8 | - | ||
| 2021/11 | 6.26 | 2.24 | -23.25 | 59.99 | -23.93 | 17.91 | 0.83 | - | ||
| 2021/10 | 6.12 | 10.48 | -23.95 | 53.73 | -24.01 | 16.88 | 0.89 | - | ||
| 2021/9 | 5.54 | 5.88 | -63.76 | 47.61 | -24.02 | 16.35 | 0.96 | 109年集團增加防護衣及隔離衣外銷營收，110年營收回復正常，部分產區短暫受到疫情影響，以致營收較去年同期減少約63.76%。 | ||
| 2021/8 | 5.23 | -6.33 | -53.23 | 42.08 | -11.21 | 16.29 | 0.96 | 109年集團增加防護衣及隔離衣外銷營收，110年營收回復正常，部分產區短暫受到疫情影響，以致營收較去年同期減少約53.23%。 | ||
| 2021/7 | 5.58 | 1.91 | -49.22 | 36.85 | 1.76 | 15.71 | 0.99 | - | ||
| 2021/6 | 5.48 | 17.81 | -31.54 | 31.26 | 24.0 | 15.01 | 0.92 | - | ||
| 2021/5 | 4.65 | -4.66 | 47.24 | 25.79 | 49.83 | 14.96 | 0.92 | - | ||
| 2021/4 | 4.88 | -10.13 | 146.52 | 21.14 | 50.41 | 16.49 | 0.84 | 109年受新冠病毒影響，非洲產區封城，致成衣訂單及營收大幅縮減，110年疫情趨緩，營收回復一般水準，故較去年同期增加50.42% | ||
| 2021/3 | 5.43 | -12.21 | 42.09 | 16.26 | 34.66 | 16.26 | 0.76 | - | ||
| 2021/2 | 6.18 | 33.01 | 61.27 | 10.83 | 31.23 | 17.94 | 0.68 | 109年受新冠病毒影響各國紛紛封城及暫停營業,致成衣訂單及營收大幅縮減,110年疫情趨緩,營收回復一般水準,故較去年同期增加61.27% | ||
| 2021/1 | 4.65 | -34.62 | 5.17 | 4.65 | 5.17 | 19.91 | 0.62 | - | ||
| 2020/12 | 7.11 | -12.76 | 36.73 | 85.98 | 23.78 | 23.31 | 0.57 | - | ||
| 2020/11 | 8.15 | 1.31 | 45.92 | 78.87 | 22.73 | 31.48 | 0.42 | - | ||
| 2020/10 | 8.05 | -47.35 | 48.76 | 70.72 | 20.52 | 34.51 | 0.39 | - | ||
| 2020/9 | 15.28 | 36.65 | 124.16 | 62.67 | 17.65 | 37.46 | 0.4 | 因受新冠病毒影響，集團9月增加防護衣及隔離衣外銷營收，營收大幅增加，以致營收較去年同期增加約124.16%。 | ||
| 2020/8 | 11.18 | 1.69 | 70.35 | 47.39 | 2.02 | 30.18 | 0.5 | 因受新冠病毒影響，集團8月增加防護衣及隔離衣外銷營收，營收大幅增加，以致營收較去年同期增加約70.35%。 | ||
| 2020/7 | 11.0 | 37.39 | 54.82 | 36.21 | -9.13 | 22.16 | 0.68 | 因受新冠病毒影響，集團7月增加防護衣及隔離衣外銷營收，營收大幅增加，以致營收較去年同期增加約54.82%。 | ||
| 2020/6 | 8.0 | 153.41 | 40.78 | 25.21 | -23.09 | 13.14 | 1.14 | - | ||
| 2020/5 | 3.16 | 59.62 | -41.61 | 17.21 | -36.49 | 8.96 | 1.67 | - | ||
| 2020/4 | 1.98 | -48.2 | -67.63 | 14.05 | -35.21 | 9.63 | 1.56 | 4月因受新冠病毒影響，南非及史瓦帝尼封城，非洲區營收大幅縮減，美洲主要銷售區營收亦下降，致營收較去年同期減少約67.64%。 | ||
| 2020/3 | 3.82 | -0.36 | -23.55 | 12.07 | -22.48 | 12.07 | 0.92 | - | ||
| 2020/2 | 3.83 | -13.25 | -13.15 | 8.25 | -21.98 | 13.45 | 0.82 | - | ||
| 2020/1 | 4.42 | -15.01 | -28.3 | 4.42 | -28.3 | 15.21 | 0.73 | - | ||
| 2019/12 | 5.2 | -6.9 | -14.59 | 69.46 | -6.51 | 0.0 | N/A | - | ||
| 2019/11 | 5.59 | 3.28 | -19.09 | 64.26 | -5.78 | 0.0 | N/A | - |
